Added to YB: 2026-02-19
Pitch date: 2026-02-17
HNGE [bullish]
Hinge Health, Inc.
+3.21%
current return
Author Info
Anders Research shares equity research primarily focused on micro/small/mid-cap biotechnology. We follow companies with mechanistically differentiated approaches to large market opportunities, with special focus in neuroscience. Sign up for the newsletter.
Company Info
Hinge Health, Inc. focuses on scaling and automating the delivery of healthcare services. The company leverages AI-powered care model, wearable devices, and access to clinicians to deliver evidence-based care services for musculoskeletal conditions.
Market Cap
$3.1B
Pitch Price
$39.30
Price Target
59.00 (+51%)
Dividend
N/A
EV/EBITDA
-5.27
P/E
-5.01
EV/Sales
4.76
Sector
Health Care Providers and Services
Category
growth
Hinge Health: More Immune to AI Than Most; A Fast-Growing, Highly Cash-Flowing Market Leader
HNGE: Digital MSK therapy leader, 46% Q4 rev growth (51% FY25), 31% FCF margin (vs 12% '24). Guides 25% '26 growth but likely conservative (assumes flat 3.9% yield vs 9% market benchmark). Trading 14.6x '26 FCF despite 20%+ growth runway, 97% retention, best-in-class product. AI defensible via healthcare barriers, proprietary data, hardware integration. 40-50% upside to Aug highs
Read full article (21 min)